China NMPA Inspection - Guangzhou Zhuangyan Biotechnology Co., Ltd. - August 23, 2023

The National Medical Products Administration (NMPA) issued an announcement on August 23, 2023, detailing the results of a recent surprise inspection at Guangzhou Zhongshang Biotechnology Co., Ltd. The inspection uncovered serious violations of regulatory standards, specifically the "Cosmetics Supervision and Management Regulations" and the "Cosmetics Production Quality Management Standards." The company acknowledged the deficiencies identified during the inspection. To ensure the safety of cosmetic products for public use, the NMPA has instructed the Guangdong Provincial Drug Administration to legally address the company's suspected unlawful practices. In response, the Guangdong Provincial Drug Administration has ordered Guangzhou Zhongshang Biotechnology Co., Ltd. to cease all production and operational activities immediately and to undertake a thorough rectification process. Concurrently, an official investigation has been initiated to fully assess the extent of the non-compliance and determine appropriate further actions. This regulatory intervention highlights the authorities' stringent oversight to maintain high quality and safety benchmarks within the cosmetics sector, prioritizing consumer welfare and adherence to established industry guidelines.